Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Julia Ann Moore"'
Autor:
Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, Neeta Somaiah, Sarina Piha‐Paul, Julia Ann Moore, Bulent Yilmaz, Deby Ogbonna, Daniel D. Karp, Ecaterina Dumbrava, Apostolia M. Tsimberidou, David S. Hong, Jordi Rodon Ahnert, Denái R. Milton, Xiaofeng Zheng, Daniel J. Booser, Nuhad K. Ibrahim, Anthony P. Conley, Priya Bhosale, Cristhiam M. Rojas Hernandez, Debasish Tripathy, Aung Naing, Funda Meric‐Bernstam
Publikováno v:
Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62f166feebf41a70e497ae249b8696a5
https://doi.org/10.1002/cncr.34773
https://doi.org/10.1002/cncr.34773
Autor:
Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, Neeta Somaiah, Sarina Anne Piha-Paul, Julia Ann Moore, Bulent Yilmaz, Daniel D. Karp, Ecaterina Elena Dumbrava, Apostolia Maria Tsimberidou, David S. Hong, Jordi Rodon Ahnert, Daniel J. Booser, Nuhad K. Ibrahim, Anthony Paul Conley, Priya Bhosale, Cristhiam Mauricio Rojas Hernandez, Debu Tripathy, Aung Naing, Funda Meric-Bernstam
Publikováno v:
Journal of Clinical Oncology. 40:3108-3108
3108 Background: Selinexor (KPT-330) is potent inhibitor of Exportin-1. In vitro, Selinexor was found to be synergistic with eribulin in triple negative breast cancer (TNBC) cell lines and enhanced antitumor activity of eribulin in TNBC patient-deriv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3d3afec55970a718ad6fd4c125a14d0
https://doi.org/10.1200/jco.2022.40.16_suppl.3108
https://doi.org/10.1200/jco.2022.40.16_suppl.3108